Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Chronic diseases like obesity and Type 2 diabetes are major challenges for employers, driving up healthcare costs and impacting workplace productivity
Just email us at [email protected] for a quick reply
The decision to continue or discontinue GLP-1 therapy should be made collaboratively with your healthcare team, weighing metabolic benefits against biliary symptom risk
p75NTR receptor: Binds all neurotrophins but with different functional outcomes than Trk receptors
Nature 491:364373 Schulte ML, Fu A, Zhao P et al (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to anti-tumor efficacy in preclinical models
US$ 26.55
US$ 23.86
US$ 21.33
US$ 21.98
